M. Brownlee

7.6k total citations · 2 hit papers
50 papers, 6.2k citations indexed

About

M. Brownlee is a scholar working on Clinical Biochemistry, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, M. Brownlee has authored 50 papers receiving a total of 6.2k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Clinical Biochemistry, 12 papers in Endocrinology, Diabetes and Metabolism and 11 papers in Molecular Biology. Recurrent topics in M. Brownlee's work include Advanced Glycation End Products research (25 papers), Natural Antidiabetic Agents Studies (8 papers) and Retinal Diseases and Treatments (7 papers). M. Brownlee is often cited by papers focused on Advanced Glycation End Products research (25 papers), Natural Antidiabetic Agents Studies (8 papers) and Retinal Diseases and Treatments (7 papers). M. Brownlee collaborates with scholars based in United States, Germany and United Kingdom. M. Brownlee's co-authors include Anthony Cerami, Helen Vlassara, Diane Edelstein, Peter Ulrich, Ida Giardino, Qida Ju, Stefanie Dimmeler, C Sui, K. Federlin and Hans‐Peter Hammes and has published in prestigious journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

M. Brownlee

50 papers receiving 5.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Aminoguanidine Prevents Diabetes-Induced Arterial Wall Protein Cross-Linking

1986 976 citations M. Brownlee, Helen Vlassara et al. profile →
Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site

2001 703 citations Diane Edelstein, M. Brownlee et al. Journal of Clinical Investigation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. Brownlee United States	36	3.0k	1.9k	1.5k	1.4k	654	50	6.2k
Peter J. Oates United States	31	2.0k 0.7×	1.5k 0.8×	2.2k 1.4×	1.8k 1.3×	423 0.6×	53	6.6k
Yasuo Ido United States	47	907 0.3×	1.4k 0.7×	4.3k 2.8×	3.7k 2.7×	390 0.6×	93	9.5k
Timothy S. Kern United States	33	1.6k 0.5×	704 0.4×	1.8k 1.2×	790 0.6×	2.0k 3.1×	64	4.9k
Xueliang Du United States	17	865 0.3×	1.1k 0.6×	1.5k 1.0×	2.5k 1.9×	209 0.3×	22	6.0k
Kamejiro Yamashita Japan	36	403 0.1×	1.4k 0.7×	1.9k 1.2×	1.2k 0.9×	238 0.4×	190	5.1k
Timothy Slattery United States	9	2.4k 0.8×	696 0.4×	2.0k 1.3×	1.4k 1.1×	42 0.1×	9	5.1k
Judy B. de Haan Australia	41	480 0.2×	407 0.2×	2.1k 1.4×	929 0.7×	165 0.3×	80	4.7k
Umberto Di Mario Italy	45	526 0.2×	2.7k 1.4×	2.0k 1.3×	1.4k 1.0×	107 0.2×	195	8.2k
Yoshihiko Nishio Japan	42	375 0.1×	1.2k 0.6×	1.8k 1.2×	1.4k 1.0×	73 0.1×	154	5.2k
Luigi Gnudi United Kingdom	41	439 0.1×	1.5k 0.8×	2.4k 1.6×	1.3k 0.9×	61 0.1×	121	5.9k

Countries citing papers authored by M. Brownlee

Since Specialization

Citations

This map shows the geographic impact of M. Brownlee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Brownlee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Brownlee more than expected).

Fields of papers citing papers by M. Brownlee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Brownlee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Brownlee. The network helps show where M. Brownlee may publish in the future.

Co-authorship network of co-authors of M. Brownlee

This figure shows the co-authorship network connecting the top 25 collaborators of M. Brownlee. A scholar is included among the top collaborators of M. Brownlee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Brownlee. M. Brownlee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Du, Xing, et al.. (2015). Neuronal overexpression of Glo1 or amygdalar microinjection of methylglyoxal is sufficient to regulate anxiety-like behavior in mice. Behavioural Brain Research. 301. 119–123. 20 indexed citations

Du, Xing, Diane Edelstein, & M. Brownlee. (2008). Oral benfotiamine plus α-lipoic acid normalises complication-causing pathways in type 1 diabetes. Diabetologia. 51(10). 1930–1932. 58 indexed citations

Nascimento, Nilberto Robson Falcão do, Lucília M. A. Lessa, Marta Regina Kerntopf, et al.. (2005). Inositols prevent and reverse endothelial dysfunction in diabetic rat and rabbit vasculature metabolically and by scavenging superoxide. Proceedings of the National Academy of Sciences. 103(1). 218–223. 93 indexed citations

Hammes, HP, M. Brownlee, Jing Lin, E. Schleicher, & Reinhard G. Bretzel. (1999). Diabetic retinopathy risk correlates with intracellular concentrations of the glycoxidation product N e -(carboxymethyl) lysine independently of glycohaemoglobin concentrations. Diabetologia. 42(5). 603–607. 79 indexed citations

Rabinovitch, Alexander, Wilma L. Suarez‐Pinzon, K Strynadka, et al.. (1999). Transfection of human pancreatic islets with an anti-apoptotic gene (bcl-2) protects beta-cells from cytokine-induced destruction.. Diabetes. 48(6). 1223–1229. 166 indexed citations

Karpoff, Howard M., Michael I. D’Angelica, Sarah L. Blair, et al.. (1997). Prevention of hepatic tumor metastases in rats with herpes viral vaccines and gamma-interferon.. Journal of Clinical Investigation. 99(4). 799–804. 39 indexed citations

Giardino, Ida, Diane Edelstein, & M. Brownlee. (1996). BCL-2 expression or antioxidants prevent hyperglycemia-induced formation of intracellular advanced glycation endproducts in bovine endothelial cells.. Journal of Clinical Investigation. 97(6). 1422–1428. 215 indexed citations

Hammes, Hans‐Peter, et al.. (1995). Aminoguanidine does not inhibit the initial phase of experimental diabetic retinopathy in rats. Diabetologia. 38(3). 269–273. 32 indexed citations

Hammes, HP, et al.. (1995). Secondary intervention with aminoguanidine retards the progression of diabetic retinopathy in the rat model. Diabetologia. 38(6). 656–660. 62 indexed citations

10.

Brownlee, M.. (1995). The pathological implications of protein glycation.. PubMed. 18(4). 275–81. 132 indexed citations

11.

Efrat, Shimon, György Fejér, M. Brownlee, & Marshall S. Horwitz. (1995). Prolonged survival of pancreatic islet allografts mediated by adenovirus immunoregulatory transgenes.. Proceedings of the National Academy of Sciences. 92(15). 6947–6951. 90 indexed citations

12.

Hammes, H. P., et al.. (1994). Aminoguanidine inhibits the development of accelerated diabetic retinopathy in the spontaneous hypertensive rat. Diabetologia. 37(1). 32–35. 99 indexed citations

13.

Fong, Yi‐Chin, et al.. (1993). Inhibition of matrix-induced bone differentiation by advanced glycation end-products in rats. Diabetologia. 36(9). 802–807. 24 indexed citations

14.

Brownlee, M., et al.. (1992). Mechanistic studies of advanced glycosylation end product inhibition by aminoguanidine. Diabetes. 41(1). 26–29. 74 indexed citations

15.

Brownlee, M.. (1991). Glycosylation Products as Toxic Mediators of Diabetic Complications. Annual Review of Medicine. 42(1). 159–166. 85 indexed citations

16.

Brownlee, M.. (1989). Pharmacological modulation of the advanced glycosylation reaction.. PubMed. 304. 235–48. 10 indexed citations

17.

Vlassara, Helen, Jay E. Valinsky, M. Brownlee, Anthony Cerami, & Satoshi Nishimoto. (1987). Advanced glycosylation endproducts on erythrocyte cell surface induce receptor-mediated phagocytosis by macrophages. A model for turnover of aging cells.. The Journal of Experimental Medicine. 166(2). 539–549. 66 indexed citations

18.

Vlassara, Helen, M. Brownlee, & Anthony Cerami. (1982). Assessment of diabetic control by measurement of urinary glycopeptides. Diabetologia. 23(3). 252–254. 3 indexed citations

19.

Brownlee, M. & Anthony Cerami. (1981). The Biochemistry of the Complications of Diabetes Mellitus. Annual Review of Biochemistry. 50(1). 385–432. 345 indexed citations

20.

Brownlee, M. & Anthony Cerami. (1980). A glucose-controlled insulin-delivery system: Semisynthetic insulin bound to lectin. Diabetologia. 19(3). 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact